HBVCare Mobile App Chronic Hepatitis B Treatment Adherence Randomized Controlled Trial
ClinicalTrials.gov Studies
Summary
NIH registered clinical trial NCT07540637, a multicenter randomized controlled trial evaluating the HBVCare mobile application for improving treatment adherence in chronic Hepatitis B patients at Hoang Long Clinic and Hanoi Medical University Hospital in Vietnam. Patients are randomized to standard care or HBVCare app intervention, with adherence outcomes assessed at three months.
What changed
This ClinicalTrials.gov registration describes NCT07540637, a randomized controlled trial assessing the HBVCare mobile application as a digital health intervention to improve medication adherence among chronic Hepatitis B patients in Vietnam. The trial enrolls patients at two sites and compares standard care against HBVCare app use over a three-month period. For compliance purposes, this is a study registry entry with no compliance obligations. Clinical researchers and healthcare providers conducting similar adherence interventions in Vietnam or comparable settings may wish to track results for evidence on digital health tool effectiveness.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Assessment of Treatment Adherence and Associated Factors in Chronic HepB Patients Supported by HBVCare
N/A NCT07540637 Kind: NA Apr 20, 2026
Abstract
Adherence to chronic Hepatitis B (HBV) treatment and regular follow-up visits is essential for preventing dangerous complications, yet adherence rates in Vietnam remain low due to barriers in patient awareness and geographic conditions. Digital health solutions, particularly mobile applications, have shown potential as tools for supporting patients in proactive disease management. The HBVCare mobile application was developed to provide features such as medication reminders, storage of lab results, and health education to improve treatment adherence and clinical outcomes. The investigators are conducting a multicenter, randomized controlled trial at Hoang Long Clinic and Hanoi Medical University Hospital to evaluate the effectiveness of HBVCare. Patients are randomized into either a control group receiving standard care and an intervention group using the HBVCare app, with patient adherence and related factors assessed after three months of treatment.
Conditions: Chronic Hepatitis B
Interventions: HBVCare Mobile App
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.